The Patent Finder

Terms ending in 2028

Biogen Ma Inc.

Every in-force patent on Biogen Ma Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,609,407Sp35 Antibodies and Uses Thereof
In force
 · Medium confidence
Biogen Ma Inc.In forceMedium confidence
US 8,399,514Treatment for Multiple Sclerosis
In force
 · High confidence
Biogen Ma Inc.In forceHigh confidence
US 8,784,823Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 9,321,840Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 8,232,064Detection and Quantitation of Cyclodextrins
In force
 · High confidence
Biogen Ma Inc.In forceHigh confidence
US 9,138,461Compositions and Methods for Increasing Vascularization
In force
 · High confidence
Sinfonia Biotherapeutics ABIn forceHigh confidence
US 7,846,438Methods of Promoting Neurite Outgrowth with Soluble Taj Polypeptides
In force
 · High confidence
Biogen Ma Inc.In forceHigh confidence
US RE44,681Compositions and Methods for Inhibiting Growth of SMAD4-DEFICIENT Cancers
In force
 · Low confidence
Biogen Ma Inc.In forceLow confidence
US D707,352Medicament Delivery Device
In force
 · High confidence
Biogen Ma Inc.In forceHigh confidence
US 8,202,698Methods of Evaluating Baff
In force
 · High confidence
Biogen Ma Inc.In forceHigh confidence
1 more term end in 2028 · Pro
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11, including 6 expiring within the 18 months from Nov 21, 2026.
Upgrade to Pro
8 of these are in force and held by Biogen Ma Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited